Our focus on cancer
Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. At MSD Oncology, helping people fight cancer is our passion and supporting accessibility to our cancer medicines is our commitment. Our focus is on pursuing research in immuno-oncology and we are accelerating every step in the journey – from lab to clinic – to potentially bring new hope to people with cancer.
Here you will find MSD resources and support related to KEYTRUDA® (pembrolizumab) in licenced indications and immunotherapy in general.
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website